Smith & Nephew (SNN) Operating Income (2009 - 2024)
Smith & Nephew (SNN) posted quarterly Operating Income of $328.0 million for Q4 2024, up 19.27% year-on-year from $275.0 million in Q1 2024, and up 19.27% on a QoQ basis from $275.0 million in Q4 2023.
Smith & Nephew (SNN) Operating Income (2009 - 2024) Analysis & Trends
Smith & Nephew (SNN) has reported Operating Income for 16 consecutive years, with $328.0 million the latest figure, recorded in Q4 2024.
- Quarterly Operating Income rose 19.27% year-over-year to $328.0 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.1 billion (up 44.34% YoY) and the FY2025 annual result came in at $794.0 million, up 20.85% from the prior year.
- Operating Income improved to $328.0 million in Q4 2024 per SNN's latest filing, from $275.0 million in the prior quarter.
- Over the last five years, Operating Income for SNN reached as high as $328.0 million in Q4 2024 and fell as low as -$5.0 million in Q4 2020.
- A 5-year average of $215.8 million and a median of $242.0 million in 2022 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2020 — Operating Income tumbled 101.19% — and 2021, when it surged 4880.0%.
- Year by year, Operating Income stood at -$5.0 million in 2020, then jumped by 4880.0% to $239.0 million in 2021, then grew by 1.26% to $242.0 million in 2022, then increased by 13.64% to $275.0 million in 2023, then advanced by 19.27% to $328.0 million in 2024.
- According to Business Quant data, Operating Income over the past three periods registered $328.0 million, $275.0 million, and $242.0 million for Q4 2024, Q4 2023, and Q4 2022 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 255.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 282.15 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 316.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 328.00 Mn |
| Dec 31, 2023 | 275.00 Mn |
| Dec 31, 2022 | 242.00 Mn |
| Dec 31, 2021 | 239.00 Mn |
| Dec 31, 2020 | -5.00 Mn |
| Dec 31, 2019 | 419.00 Mn |
| Dec 31, 2018 | 372.00 Mn |
| Dec 31, 2017 | 414.00 Mn |
| Dec 31, 2016 | 357.00 Mn |
| Dec 31, 2015 | 439.00 Mn |
| Dec 31, 2014 | 363.00 Mn |
| Sep 30, 2014 | 160.00 Mn |
| Mar 31, 2014 | 226.00 Mn |
| Dec 31, 2013 | 207.00 Mn |
| Mar 31, 2013 | 235.00 Mn |
| Dec 31, 2012 | 213.00 Mn |
| Jun 30, 2012 | 233.00 Mn |
| Mar 31, 2012 | 213.00 Mn |
| Dec 31, 2011 | 862.00 Mn |
| Sep 30, 2011 | -457.00 Mn |